Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1991

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Hormonal contraception. [Gormonalnaia kontratseptsiia.]

AUTHORS

Prilepskaia VN

SOURCE

AKUSHERSTVO I GINEKOLOGIIA. 1991 Dec;(12):63-7.

ABSTRACT

Effective contraceptives contribute to the regulation of births, protect the health of women, reduce maternal and

perinatal mortality and gynecological diseases, and prevent abortion-related complications. Complications after

abortion average 30%, and among primigravidas the rate reaches 45%. Abortion can result in sterility and in the

inability to carry out the pregnancy. Oral contraceptives (OCs) are used by 150 million globally. In new preparations

ethinyl estradiol (EE) and levonorgestrel (LNG) are the most common components. In the 2-phase and 3-phase

preparations Sequilar, Anteovin, and lipid profile safe Triquilar the gestagen component was reduced 40%.

Continuin and Famulen are minipills, and Postinor is a postcoital contraceptive. Absolute contraindications of OCs

include thromboembolytic diseases, severe cardiovascular system diseases, liver disorders, cirrhosis, cerebral

vascular diseases, grave diabetes, jaundice, and malignant tumors of the mammae and sexual organs. Rigevidon,

Triquilar, and Trisiston have high steroid content with minimal side effects. The protective effect of OCs are: 2-3

times lower risk of inflammation of the small pelvis, lower risk of malignant and benign ovarian tumors that lasts even

after discontinuation, uterine cancer prevention (antiproliferation effect on the endometrium and inhibition of mitotic

activity of the myometrium), and reduced risk of benign breast neoplasms. The finding that estrogen-induced risk of

breast cancer increases with longterm contraceptive use in young nulliparas has not been persuasively proven. The

optimal duration of uninterrupted OC use is 1-1.5 years. Monophasic estrogen-gestagen preparations include

Bisecurin, Non-Ovlon, Ovidon, Rigevidon, Minisiston, and Demulen with low dosages of EE, LNG, norethisterone

acetate, and diacetate ethonodiol. Norplant is a subdermal silastic capsule with effectiveness for up to 5 years.

(PubHealth.info Document ID: CONT3T 2048-06)

PubHealth.info NOTE: The author(s) of this article titled, "Hormonal contraception. [Gormonalnaia kontratseptsiia.]",

is(are) Prilepskaia VN. The source of this article is "AKUSHERSTVO I GINEKOLOGIIA. 1991 Dec;(12):63-7.". This

article was published in 1991 in Russian language(s). (PubHealth.info® Document ID: CONT3T 2048-06. All rights

reserved with PubHealth.info) PIN: 12048

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.